• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒-乙型肝炎病毒、人类免疫缺陷病毒-丙型肝炎病毒和乙型肝炎病毒-丙型肝炎病毒合并感染的研究进展:患病率、危险因素、发病机制、诊断和治疗

Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment.

作者信息

Shahriar Sagarika, Araf Yusha, Ahmad Rasel, Kattel Pravakar, Sah Ganga Sagar, Rahaman Tanjim Ishraq, Sadiea Rahila Zannat, Sultana Shahnaj, Islam Md Sayeedul, Zheng Chunfu, Hossain Md Golzar

机构信息

Biotechnology Program, Department of Mathematics and Natural Sciences, BRAC University, Dhaka, Bangladesh.

Department of Genetic Engineering and Biotechnology, School of Life Sciences, Shahjalal University of Science and Technology, Sylhet, Bangladesh.

出版信息

Front Microbiol. 2022 Feb 3;12:780887. doi: 10.3389/fmicb.2021.780887. eCollection 2021.

DOI:10.3389/fmicb.2021.780887
PMID:35222296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8865087/
Abstract

Human immunodeficiency virus, hepatitis B virus, and hepatitis C virus are three blood-borne viruses that can cause major global health issues by increasing severe morbidity. There is a high risk of coinfection with these viruses in individuals because of their same transmission routes through blood using shared needles, syringes, other injection equipment, sexual transmission, or even vertical transmission. Coinfection can cause various liver-related illnesses, non-hepatic organ dysfunction, followed by death compared to any of these single infections. The treatment of coinfected patients is complicated due to the side effects of antiviral medication, resulting in drug resistance, hepatotoxicity, and a lack of required responses. On the other hand, coinfected individuals must be treated with multiple drugs simultaneously, such as for HIV either along with HBV or HCV and HBV and HCV. Therefore, diagnosing, treating, and controlling dual infections with HIV, HBV, or HCV is complicated and needs further investigation. This review focuses on the current prevalence, risk factors, and pathogenesis of dual infections with HIV, HBV, and HCV. We also briefly overviewed the diagnosis and treatment of coinfections of these three blood-borne viruses.

摘要

人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒是三种血源性病毒,它们可通过增加严重发病率引发重大的全球健康问题。由于这些病毒通过共用针头、注射器、其他注射设备、性传播甚至垂直传播等相同的血液传播途径,个体同时感染这些病毒的风险很高。与任何一种单一感染相比,合并感染可导致各种肝脏相关疾病、非肝脏器官功能障碍,进而导致死亡。由于抗病毒药物的副作用,合并感染患者的治疗很复杂,会产生耐药性、肝毒性以及缺乏所需的反应。另一方面,合并感染的个体必须同时接受多种药物治疗,例如治疗HIV时同时治疗HBV或HCV以及HBV和HCV。因此,诊断、治疗和控制HIV、HBV或HCV的双重感染很复杂,需要进一步研究。本综述重点关注HIV、HBV和HCV双重感染的当前流行情况、危险因素和发病机制。我们还简要概述了这三种血源性病毒合并感染的诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/a86649dcb810/fmicb-12-780887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/9e4e0416c6d2/fmicb-12-780887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/c6d7cefc2c81/fmicb-12-780887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/1037fce22203/fmicb-12-780887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/a86649dcb810/fmicb-12-780887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/9e4e0416c6d2/fmicb-12-780887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/c6d7cefc2c81/fmicb-12-780887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/1037fce22203/fmicb-12-780887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/8865087/a86649dcb810/fmicb-12-780887-g004.jpg

相似文献

1
Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment.人类免疫缺陷病毒-乙型肝炎病毒、人类免疫缺陷病毒-丙型肝炎病毒和乙型肝炎病毒-丙型肝炎病毒合并感染的研究进展:患病率、危险因素、发病机制、诊断和治疗
Front Microbiol. 2022 Feb 3;12:780887. doi: 10.3389/fmicb.2021.780887. eCollection 2021.
2
Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.HIV患者中乙型肝炎病毒和丙型肝炎病毒合并感染的影响与管理
Trop Gastroenterol. 2008 Jul-Sep;29(3):136-47.
3
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.血吸虫物种与乙型肝炎或丙型肝炎病毒的合并感染。
Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5.
4
Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.非洲人类免疫缺陷病毒感染者中乙型肝炎病毒和/或丙型肝炎病毒感染的流行病学:系统评价和荟萃分析。
PLoS One. 2022 May 31;17(5):e0269250. doi: 10.1371/journal.pone.0269250. eCollection 2022.
5
Changing Epidemiology of Hepatitis B Virus and Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus-Positive Population in China: Results From the Third and Fourth Nationwide Molecular Epidemiologic Surveys.中国人类免疫缺陷病毒阳性人群中乙型肝炎病毒和丙型肝炎病毒合并感染的流行情况变化:来自第三次和第四次全国分子流行病学调查的结果。
Clin Infect Dis. 2021 Aug 16;73(4):642-649. doi: 10.1093/cid/ciab058.
6
HIV-HBV and HIV-HCV Coinfection and Liver Cancer Development.人类免疫缺陷病毒-乙型肝炎病毒和人类免疫缺陷病毒-丙型肝炎病毒合并感染与肝癌发生
Cancer Treat Res. 2019;177:231-250. doi: 10.1007/978-3-030-03502-0_9.
7
Management of HIV and hepatitis virus coinfection.HIV 和肝炎病毒合并感染的管理。
Expert Opin Pharmacother. 2010 Oct;11(15):2497-516. doi: 10.1517/14656566.2010.500615.
8
Drug-resistant and immune-escape hepatitis B virus mutants, occult hepatitis B infection and coinfections in public hospital patients from Argentina.阿根廷公立医院患者中的耐药和免疫逃逸乙型肝炎病毒突变株、隐匿性乙型肝炎感染和合并感染。
Virus Genes. 2021 Aug;57(4):327-337. doi: 10.1007/s11262-021-01850-z. Epub 2021 Jun 6.
9
Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.马拉维住院患者中乙型和丙型肝炎病毒感染率及与艾滋病毒的合并感染情况
J Infect. 2008 Jul;57(1):72-7. doi: 10.1016/j.jinf.2008.05.004. Epub 2008 Jun 13.
10
Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy: An observational cross-sectional study.意大利HIV-1感染囚犯血源性HIV、HCV和HBV感染的相关因素及分子特征:一项观察性横断面研究。
Medicine (Baltimore). 2016 Nov;95(44):e5257. doi: 10.1097/MD.0000000000005257.

引用本文的文献

1
Ultrasensitive and Multiplexed Target Detection Strategy Based on Photocleavable Mass Tags and Mass Signal Amplification.基于光可裂解质量标签和质量信号放大的超灵敏多重目标检测策略
Nanomaterials (Basel). 2025 Jul 29;15(15):1170. doi: 10.3390/nano15151170.
2
From Management to Cure: The Shifting Paradigm in HIV and Chronic Viral Hepatitis.从管理到治愈:HIV与慢性病毒性肝炎领域不断转变的范式
Pharmaceuticals (Basel). 2025 Jul 11;18(7):1034. doi: 10.3390/ph18071034.
3
AMPK activation by hepatitis E virus infection inhibits viral replication through attenuation of autophagosomes and promotion of innate immunity.

本文引用的文献

1
The Effect of HBV/HCV in Response to HAART in HIV Patients after 12 Months in Kumba Health District in the South West Region of Cameroon.喀麦隆西南地区昆巴卫生区HIV患者接受高效抗逆转录病毒治疗12个月后HBV/HCV对治疗反应的影响
Trop Med Infect Dis. 2021 Aug 10;6(3):150. doi: 10.3390/tropicalmed6030150.
2
Frequency of Hepatitis B, C and HIV Infections among Transfusion-Dependent Beta Thalassemia Patients in Dhaka.达卡依赖输血的β地中海贫血患者中乙型肝炎、丙型肝炎和艾滋病毒感染的发生率
Infect Dis Rep. 2021 Jan 15;13(1):89-95. doi: 10.3390/idr13010011.
3
Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
戊型肝炎病毒感染激活AMPK通过减弱自噬体和促进天然免疫来抑制病毒复制。
Cell Mol Life Sci. 2025 Mar 13;82(1):111. doi: 10.1007/s00018-025-05634-8.
4
Evaluating the Efficacy of Repurposed Antiretrovirals in Hepatitis B Virus Treatment: A Narrative Review of the Pros and Cons.评估重新利用的抗逆转录病毒药物在乙型肝炎病毒治疗中的疗效:利弊的叙述性综述
Int J Mol Sci. 2025 Jan 23;26(3):925. doi: 10.3390/ijms26030925.
5
Screening of genes co-associated with osteoporosis and chronic HBV infection based on bioinformatics analysis and machine learning.基于生物信息学分析和机器学习的与骨质疏松症和慢性乙型肝炎感染相关的基因联合筛查。
Front Immunol. 2024 Sep 16;15:1472354. doi: 10.3389/fimmu.2024.1472354. eCollection 2024.
6
Comorbidities and Monitoring in Patients with Chronic Hepatitis B on Nucleos(t)ide Analogues Attending a Tertiary Hospital in Malaysia, Southeast Asia: A Critical Perspective.东南亚马来西亚一家三级医院中接受核苷(酸)类似物治疗的慢性乙型肝炎患者的合并症与监测:批判性视角
Malays J Med Sci. 2024 Aug;31(4):149-161. doi: 10.21315/mjms2024.31.4.12. Epub 2024 Aug 27.
7
Hepatitis B prevalence and risk factors among adults living with HIV in South Africa: a clinic-based cohort study.南非 HIV 感染者中乙型肝炎的流行情况及危险因素:一项基于诊所的队列研究。
BMC Infect Dis. 2024 Aug 31;24(1):891. doi: 10.1186/s12879-024-09746-7.
8
Testing Hepatitis E Seroprevalence among HIV-Infected Patients in Greece: The SHIP Study.希腊HIV感染患者戊型肝炎血清流行率检测:SHIP研究
Pathogens. 2024 Jun 24;13(7):536. doi: 10.3390/pathogens13070536.
9
Prevalence of hepatitis B and C infections among HIV-positive men who have sex with men: A systematic review and meta-analysis.男男性行为者中艾滋病毒感染者的乙型和丙型肝炎感染率:一项系统评价和荟萃分析。
Health Sci Rep. 2024 Jun 26;7(6):e2206. doi: 10.1002/hsr2.2206. eCollection 2024 Jun.
10
Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman.阿曼一家三级护理中心慢性丙型肝炎患者的生存预测因素。
Saudi J Gastroenterol. 2024 Jan 1;30(1):45-52. doi: 10.4103/sjg.sjg_201_23. Epub 2023 Sep 20.
丙型肝炎病毒(HCV)相关肝硬化患者接受直接抗病毒药物(DAA)治疗后的临床结局取决于疾病的严重程度。
J Hepatol. 2021 May;74(5):1053-1063. doi: 10.1016/j.jhep.2020.11.021. Epub 2020 Nov 23.
4
Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?长期 TDF 联合 ART 治疗与 HIV-HBV 合并感染中 HBsAg 丢失的进展率——对功能性 HBV 治愈的启示?
J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):527-533. doi: 10.1097/QAI.0000000000002386.
5
Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.南非艾滋病毒时代的乙型肝炎病毒相关肝细胞癌
BMC Gastroenterol. 2020 Jul 13;20(1):226. doi: 10.1186/s12876-020-01372-2.
6
Impact of the Interaction of Hepatitis B Virus with Mitochondria and Associated Proteins.乙型肝炎病毒与线粒体及其相关蛋白相互作用的影响。
Viruses. 2020 Feb 4;12(2):175. doi: 10.3390/v12020175.
7
Hepatitis B Virus Infection in Tanzania: Current Status and Challenges.坦桑尼亚的乙型肝炎病毒感染:现状与挑战
J Trop Med. 2018 Jan 30;2018:4239646. doi: 10.1155/2018/4239646. eCollection 2018.
8
Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.尼泊尔 HIV 感染人群中乙型肝炎病毒和/或丙型肝炎病毒感染的流行病学特征和危险因素。
Biomed Res Int. 2018 Jan 2;2018:9241679. doi: 10.1155/2018/9241679. eCollection 2018.
9
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals.接受直接抗病毒药物治疗的丙型肝炎病毒/乙型肝炎病毒肝硬化患者的乙肝病毒再激活
J Viral Hepat. 2018 Jan;25(1):72-79. doi: 10.1111/jvh.12754. Epub 2017 Aug 9.
10
Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling.丙型肝炎病毒在注射吸毒人群中的生物行为学调查——对反应驱动抽样理论假设敏感性的系统评价。
Harm Reduct J. 2017 Jul 11;14(1):44. doi: 10.1186/s12954-017-0172-z.